行情

AEMD

AEMD

Aethlon Med
NASDAQ

实时行情|Nasdaq Last Sale

1.280
-0.030
-2.29%
盘后: 1.330 +0.05 +3.91% 18:06 04/03 EDT
开盘
1.320
昨收
1.310
最高
1.389
最低
1.230
成交量
21.06万
成交额
--
52周最高
13.74
52周最低
0.7640
市值
1,198.69万
市盈率(TTM)
-0.2840
分时
5日
1月
3月
1年
5年

分析师评级

1位分析师的综合评级

买入

免责声明:分析师观点仅供投资者决策参考,不构成任何买卖投资建议。

目标价格预测

分析师预测AEMD价格均价为3.000,最高价位3.000,最低价为3.000。

EPS

AEMD 新闻

更多
  • 毕马威首席经济学家:冠状病毒导致的失业比大衰退时期更糟
  • 新浪美股 · 1小时前
  • 欧佩克+会议推迟 沙特与俄罗斯紧张局势升级 周一油价料将暴跌
  • 新浪美股 · 3小时前
  • 迪拜将人员流动限制措施扩大至24小时限制
  • 新浪美股 · 4小时前
  • 特朗普称将申请更多中小企业纾困资金
  • 央视 · 5小时前

所属板块

先进医疗设备和技术
-1.50%
医疗设备和用品
-1.17%

热门股票

代码
价格
涨跌幅

AEMD 简况

Aethlon Medical, Inc. is a medical device company focused on creating devices for cancer, infectious disease and other life-threatening conditions. The Company operates through two segments: Aethlon, which represents its therapeutic business activities, and ESI, which represents its diagnostic business activities. The Company's lead product is the Aethlon Hemopurifier, which is a device that selectively targets the elimination of circulating viruses and tumor-secreted exosomes that promote cancer progression. The Aethlon Hemopurifier sheds glycoproteins to treat infectious viral pathogens. In oncology indications, the Hemopurifier targets the removal of circulating exosomes, which are released to promote cancer progression and to seed the spread of metastasis. Through its subsidiary, Exosome Sciences, Inc. (Exosome), the Company is also developing exosome-based product candidates to diagnose and monitor neurological disorders and cancer.
展开

微牛提供Aethlon Medical, Inc.(NASDAQ-AEMD)的股票价格,实时市场报价,专业分析师评级,深度图表和免费的AEMD股票新闻,以帮助您做出投资决策。